Exagen 10% owner Jorey Chernett reports sale of common shares worth $69,167.10

XGN•2026-11-11

Exagen 10% owner Jorey Chernett sold 11,265 common shares at $6.14 each on November 6, 2026. He reported purchases of 8,500 shares at $6.35 each on November 9 and 7,085 shares at $5.26 each on November 10, with direct beneficial ownership of 2,625,625 shares.

Exagen 10% owner Jorey Chernett reports sale of common shares worth $69,167.10

1. Share transactions

Related News

Teradyne publishes CRR report

Ashford Trust swings to Q3 2026 net income attributable to common stockholders of $2.47 million

AGNT files initial beneficial ownership statement for CMO Kortney Robinson Osborne

Sources

Exagen 10% owner Jorey Chernett reports sale of common shares worth $69,167.10

Dollar gains traction as Fed speakers warn of risks from inflation

Immutep reports 81.1% 12-month disease-free survival in Phase II sarcoma trial